BLT - Blis Technologies

[Phaedrus]

My movements haven't been effected by taking K12

What you are saying there Emearg, is that K12 has failed to cure your constipation!!!!

I think (hope!) you really mean affected, in that K12 has not altered your normal bowel movements.

[Cannibal]

Well done Phaedrus. As a grammar pedant I was tempted to comment but not brave enough.

I was thinking of starting an Off Topic thread with examples of the stunning typos on here!

Disclosure - I am a member of the Facebook group, "If you can't tell the difference between your and you're, you deserve to die."

Harsh but fair in my opinion.

[emearg]

As a grammar pedant I was tempted to comment but not brave enough.

I think you may have missed out a word from that sentence Cannibal? ;-)

Anywho, I should have thought about what I was saying before my fingers went wild!

Hopefully I get my to vs too vs two right and my your vs you're and amount vs quantity vs number of something right not to mention a few others.

I will take more note of effect vs affect in the future...

I'm not Simla but do share much of his optimism for the future of Blis.

[neopoleII]

regarding bowl movements,
k12 might be killing the bad bugs that cause upset tummies,
so another use for k12 might be in the 3rd world, where lack of hygene induced sickness prevails.
endless opurtunity.........

i think a study should be made at the local hospital with patients of different ills getting a free dose of k12 to see what happens....................

it seems k12 has yet to be fully appreciated

i remember several years ago a poster mentioned that his hair stopped falling out once taking k12 on a regular basis........ a reason hair falls out is that bacteria on the scalp can kill hair folicals,
which is why it is important to dry hair properly, and folks who wear hats all the time have a higher probability of hair lose because of the humid conditions under their hats.

[emearg]

Having reread one of Frutarom's press releases (text is below) it makes me wonder how hard it will be for Frutarom to sell the concept of K12 to their customers? The quotes "hundreds of times more effective than even most traditional antiseptic throat lozenges if used as an oral antiseptic" and "this research suggests that if you are already sick, BLIS K12 can stimulate an immune response to help a person recover faster” makes me wonder how many of their customers wouldn't want to introduce a product based on this probiotic? Considering all the studies on it's safety and efficacy makes it a bit of a no brainer really doesn't it?


New Data on Probiotic BLIS K12 Effectiveness in Supporting Respiratory Health and Stimulating Immune System
2008-12-16 - Frutarom USA Inc.

Frutarom USA Inc. is able to present new data on the effectiveness of their new oral cavity probiotic, BLIS K12 from BLIS Technologies Ltd in New Zealand. Frutarom has exclusive distribution rights to this product.

Frutarom completed a marketing and supply agreement with BLIS Technologies Ltd, which was announced last month at SupplySide West. Frutarom is now able to present new independent scientific data from Germany and Canada which points to why this probiotic organism, BLIS K12, seems to be so effective in protecting the oral cavity.

BLIS K12 is the world’s only probiotic specifically designed to protect the entire oral cavity which includes the throat, mouth, gums and teeth. Under specific conditions, it has even been shown to protect the nasal sinus from infection. BLIS K12 is known as an advanced probiotic, because unlike other probiotic organisms, it will produce antibacterial peptides (called BLIS) when it is under threat from a potential disease-causing bacteria. Studies on the potency of the antibacterial effect of the advanced probiotic organism demonstrates that it is hundreds of times more effective than even most traditional antiseptic throat lozenges if used as an oral antiseptic.

Jocelyn Mathern, (M.S., R.D.), Technical Health Manager for Frutarom, reported that a research group from the University of British Columbia, Vancouver, Canada, recently published a paper on the unique properties of the organism BLIS K12, in the scientific journal from the American Society of Microbiology, called “Infection and Immunity”. The research paper went beyond examining the classic probiotic activity of certain bacteria to determine if the BLIS K12 probiotic conferred any additional benefit, simply by colonizing in the oral cavity.

“What’s exciting about this research is that it showed that BLIS K12 exhibited a pronounced anti-inflammatory effect and this was directly related to its interaction and colonization with its host (i.e. the person taking it). This demonstrates that the human body actually responds in positive and beneficial ways, in the presence of BLIS K12, unlike many of the other bacteria that can be found within the human body.” Mathern said. “Additionally the study also suggested that the BLIS K12 could switch on the genes in the epithelial tissue that are responsible for cellular rebuilding and repair, especially after a cell has been damaged by a pathogen.”

The research group that investigated BLIS K12 took several months to complete their work and involved researchers from the University of British Columbia (Canada), University of Leeds (UK), Inimex Pharmaceuticals (Canada), and the University of Otago (New Zealand). They now confirm that the beneficial effects of the probiotic BLIS K12 goes beyond the unique ability to produce its well-known, anti-bacterial peptides (called BLIS), which are clinically demonstrated to kill bacteria implicated in upper airways infection, chronic bad breath and bacterial infections of the oral cavity. “We know that BLIS K12 has protective benefits against sore throats and upper respiratory infections, but this research suggests that if you are already sick, BLIS K12 can stimulate an immune response to help a person recover faster,” stated Mathern.

Just prior to this publication from the group at the University of British Columbia, another important study appeared in the European Journal of Clinical Microbiology & Infectious Diseases. In this earlier study it was suggested that the advanced probiotic, BLIS K12, could exert a long term protective effect upon the upper respiratory tract (ear, nose and throat) if the subjects sucked on a series of BLIS K12 lozenges immediately after a course of antibiotics. The study suggested that BLIS K12 had the potential for unique application of protection against ear infections in children.

INFECTION AND IMMUNITY, Sept. 2008, p. 4163–4175 Vol. 76, No. 9
DR. M. ROHDE, HELMHOLTZ CENTRE FOR INFECTION RESEARCH, Braunschweig, Germany
MICROBE Oct 2008, Commentary on Infect. Immun. 76:4163–4175
EUR J CLIN MICROBIOL INFECT DIS, DOI 10.1007/S10096-008-0569-4

[simla]

Well, that's the million dollar question, Emearg. Just how saleable is this science? On paper it looks good, but you could probably say similar things about an apple, yet most people will buy a burger instead. How many people do you know who buy probiotics, or even bother talking about it? Probiotics is very much a niche market so far.

Of course, Blis only needs the niche market to do very well indeed anyway, but I'm intellectually very curious to see whether the concept is strong enough to hit the broader public in the end. You can see K12 succeeding in the niche health-supplement end of the market. And they are also trying hard to break into broader consumer areas, but the question is whether the products can have broad popular appeal. Can you sell a product widely that consumers can't understand easily? We all buy "added fibre", for example, because we understand that it "helps prevents cancer" or "keeps us regular" - in other words, we do think we understand it (really we have probably just memorised the advertising slogans.)

So, I'm not sure how broadly K12 will appeal until there's an easy catch phrase for it. Can you describe what it does in 5 catchy words or less, which is the attention span needed in any promo? "Prevents most coughs, colds and flus" would be great if that was proven, but what can we say currently? "More effective than even most traditional antiseptic throat lozenges if used as an oral antiseptic" just doesn't grab people, does it? "Neutralises bad breath" will sell, but that is a niche market again.

But M18, now, that's easy: "Helps stop teeth from rotting", or "Cuts dentist's fees", or some such. We all know the slogan: "Keeps teeth clean and healthy", for example. That's got a great chance of hitting the mainstream market, which is why I see it as a game changer for Blis. That science is definitely saleable.

[simla]

A bit off-topic. But many here seem to like the health side of Blis. So you might enjoy this, with some parallels to Blis, though obviously rather different.

http://www.telegraph.co.uk/health/we...t-disease.html

[simla]

And still a bit off-topic, here's an American gentleman lamenting that Americans don't hold their stocks either. His graph compares now with 1929.

http://dailyreckoning.com/stop-trading/

Very interesting to note from the graph how many people became "holders" after 1929.

[Impatient]

Pheew, glad I sold out at 8.3c (albeit at a 60% loss)....these very, very promising shares seem to be in free fall right now. Good luck everyone :-)

[emearg]

It sure is a pretty negative day on the market with a lot of red on the board!

Not that I am very interested in short term ups and downs it is interesting to see that the BLT selling frenzy seems to be coming to an end. 3,000 on offer at 6.9 cents and then the next lowest offer is 9.1 cents.

I wonder if work is being done to get K12 into milk powder? It struck me yesterday that it might be quite possible/practical. Considering that a large portion of the global population get their milk from milk powder the market could be very significant. I wonder if the newly annouced consumer products company might be looking at milk powder?

Any thoughts?